2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Granulocytic Leukemia in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roehm, NW | 1 |
| Rodgers, GH | 1 |
| Hatfield, SM | 1 |
| Glasebrook, AL | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Granulocytic Leukemia
| Article | Year |
|---|---|
An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.
Topics: Animals; Cell Division; Cell Survival; Colorimetry; Coloring Agents; Concanavalin A; Dose-Response R | 1991 |